Fundamental Analysis of Zymeworks Inc. Common Stock - Growth / Value Index
ZYME - Valuation Highlights
Valuation Analysis
Tsr Value Index - Poor Score of 20.31
Price to Book Ratio of 1864.84 suggesting that it is very expensive
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -5595.64 | 3059996 | 63938832 % | |
| Price to Book | 1889.70 | 1351.17 | 111830 % | 1.59 |
| Price to Sales | 3191711 | 1360613 | 94312534 % | |
| Enterprise Value to EBITDA Multiple | 4.58 | 2834609 | 216502816 % |
ZYME - Profitability Highlights
Profitability Analysis
Strong Return On Capital Employed of 44.16
Company Earning excess return
Piotroski F Score - Stable Value of 4.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Tsr Profitability Index - Very Poor Score of 5.00
Very Low Dividend Yield of 0 %
Company Net profit is Negative for last 5 Quarters
EPS decline for last four quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -33.85 | 0.0442 | -99.82 % | -7.23 |
| Return On Asset | -25.76 | 0.0353 | -99.82 % | -5.72 |
| Net Profit Margin | -57039.25 | 44.46 | 47.50 % | -315.58 |
| Operating Profit Margin | -66091.26 | 44.35 | 40.16 % | -376.89 |
| EBITDA Margin | -66067.00 | 47.99 | 31.23 % | -376.89 |
Highlights
| Market Cap | 644828 K |
| Enterprise Value | -152651.17 M |
| Price/Book TTM | 1889.70 |
| Outstanding Share | 70704.90 K |
| Float/ Outstanding Share | 60.66% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0.0179 |
| Piotroski F Score | 4.00 |
| Altman Z Score | -1.63 |
| Sloan Ratio | 0.0000 |
| Peter Lynch Fair Value | 0 |
ZYME - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 47.50%
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 50464.00 K | 11.90 % | 40.74 % |
| Gross Profit | 50464.00 K | 81.57 % | 40.74 % |
| EBITDA | -33340.05 M | 46.85 % | 239.52 % |
| Net Profit | -28784.29 M | 65.06 % | 118.57 % |
| EPS | -0.0016 | 100.00 % | NA |
ZYME - Stability Highlights
Stability Analysis
Cash ratio of 6.71
Company financial liquidity has improved
Altman Z Score of -1.63 suggest high risk
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0092 | 36.03 % | 0.0095 |
| Cash Ratio | 6.71 | 30.41 % | |
| Quick Ratio | 7.41 | 0 % | 6.92 |
| Shareholders Equity | 80.02 | 5.30 % | |
| Debt to EBITDA | 19.24 | 87243.30 % |
Historical Valuation Ratios of Zymeworks Inc. Common Stock
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Zymeworks Inc. Common Stock
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Zymeworks Inc. Common Stock
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Zymeworks Inc. Common Stock
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)